Newton Charles W. insider trades

Newton Charles W. has filed 22 Form 4s with the SEC that we hold, for Lyell Immunopharma, Inc. (LYEL) (Chief Financial Officer), Coherus Oncology, Inc. (CHRS) (Director), Keros Therapeutics, Inc. (KROS) (Director) and Novavax INC (NVAX) (Director), among 5 companies in all. Across all of them we count 1 purchase worth $112.0K and 5 sales worth $29.3K reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($11.2K). The largest single trade was a purchase of 200,000 shares of Lyell Immunopharma, Inc. worth $112.0K, dated 2025-03-17. Of 1 sale filed since we began reading the 10b5-1 checkbox, 1 (100%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-03-18 and the latest 2026-08-20.